Live feed
Filing
SCHEDULE 13D
SCHEDULE 13D0001699737-25-000014·Rani Therapeutics Holdings, Inc.
Schedule 13D ownership disclosure
RANI THERAPEUTICS HLDGS INC
Class A Common Stock, $0.0001 par value per share · CUSIP: 753018100
Event date: 2025-10-23
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- Samsara BioCapital, L.P.Reported CIK 0001699737
Shares: 4,941,239.00 · Class: 5.0%
- Samsara BioCapital GP, LLCReported CIK 0001888829
Shares: 4,941,239.00 · Class: 5.0%
- Samsara Opportunity Fund, L.P.Reported CIK 0002086193
Shares: 4,941,238.00 · Class: 5.0%
- Samsara Opportunity Fund GP, LLCReported CIK 0002086456
Shares: 4,941,238.00 · Class: 5.0%
- Srinivas AkkarajuReported CIK 0001253170
Shares: 9,882,477.00 · Class: 9.9%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001699737-25-000014
- Form type
- SCHEDULE 13D
- Filer
- Rani Therapeutics Holdings, Inc.
- CIK
- CIK 1856725
- Filed
- Oct 30, 2025
- Reporting period
- Oct 23, 2025
- Description
- Schedule 13D beneficial ownership